Lexicon Pharmaceuticals To Participate In The 42nd Annual JPMorgan Healthcare Conference
THE WOODLANDS, Texas, Dec. 21, 2023 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced its participation in the...
Read moreTHE WOODLANDS, Texas, Dec. 21, 2023 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced its participation in the...
Read moreNew York, New York, Dec. 21, 2023 (GLOBE NEWSWIRE) -- Alphatime Acquisition Corp (Nasdaq: ATMC, ATMCU, ATMCR, and ATMCW) (the...
Read moreCLEVELAND, OHIO, Dec. 21, 2023 (GLOBE NEWSWIRE) -- Range Impact, Inc. (OTC: RNGE) (“Range Impact”), a public company dedicated to...
Read moreHOUSTON, Dec. 21, 2023 (GLOBE NEWSWIRE) -- Great Lakes Dredge & Dock Corporation ("Great Lakes" or the “Company”) (NASDAQ: GLDD),...
Read moreSEATTLE, Dec. 21, 2023 (GLOBE NEWSWIRE) -- Banzai International, Inc. (NASDAQ: BNZI) (“Banzai” or the “Company”), a leading marketing technology...
Read moreSecond quarter sales of $545 million, up 16% over the prior yearSecond quarter GAAP diluted earnings per share from continuing...
Read moreST. LOUIS, Dec. 21, 2023 (GLOBE NEWSWIRE) -- Stifel Financial Corp. (NYSE: SF) today reported selected operating results for November...
Read moreNEW YORK, Dec. 21, 2023 (GLOBE NEWSWIRE) -- Hudson Acquisition I Corp. (the "Company" or "Hudson") (Nasdaq: HUDA), announced today...
Read moreOXNARD, Calif., Dec. 21, 2023 (GLOBE NEWSWIRE) -- Mission Produce, Inc. (Nasdaq: AVO) (“Mission” or the “Company”), a world leader...
Read moreSix of ten evaluable myelofibrosis patients who received GB2064 monotherapy for at least six months experienced a ≥ 1-grade reduction...
Read more